115 related articles for article (PubMed ID: 15629900)
1. Over-expressed IgG2 antibodies against O-acetylated sialoglycoconjugates incapable of proper effector functioning in childhood acute lymphoblastic leukemia.
Bandyopadhyay S; Bhattacharyya A; Mallick A; Sen AK; Tripathi G; Das T; Sa G; Bhattacharya DK; Mandal C
Int Immunol; 2005 Feb; 17(2):177-91. PubMed ID: 15629900
[TBL] [Abstract][Full Text] [Related]
2. Antibodies against 9-O-acetylated sialic acids in childhood acute lymphoblastic leukemia: a two-year study with 186 samples following protocol MCP 943.
Bandyopadhyay S; Chatterjee M; Banavali SD; Pal S; Nair CN; Advani SH; Mandal C
Indian J Biochem Biophys; 2006 Feb; 43(1):7-14. PubMed ID: 16955745
[TBL] [Abstract][Full Text] [Related]
3. Detection of immune-complexed 9-O-acetylated sialoglycoconjugates in the sera of patients with pediatric acute lymphoblastic leukemia.
Bandyopadhyay S; Mukherjee K; Chatterjee M; Bhattacharya DK; Mandal C
J Immunol Methods; 2005 Feb; 297(1-2):13-26. PubMed ID: 15777927
[TBL] [Abstract][Full Text] [Related]
4. Purification and characterization of 9-O-acetylated sialoglycoproteins from leukemic cells and their potential as immunological tool for monitoring childhood acute lymphoblastic leukemia.
Pal S; Ghosh S; Mandal C; Kohla G; Brossmer R; Isecke R; Merling A; Schauer R; Schwartz-Albiez R; Bhattacharya DK; Mandal C
Glycobiology; 2004 Oct; 14(10):859-70. PubMed ID: 15190007
[TBL] [Abstract][Full Text] [Related]
5. Purification, characterization of O-acetylated sialoglycoconjugates-specific IgM, and development of an enzyme-linked immunosorbent assay for diagnosis and follow-up of indian visceral leishmaniasis patients.
Bandyopadhyay S; Chatterjee M; Pal S; Waller RF; Sundar S; McConville MJ; Mandal C
Diagn Microbiol Infect Dis; 2004 Sep; 50(1):15-24. PubMed ID: 15380274
[TBL] [Abstract][Full Text] [Related]
6. Antibodies against 9-O-acetylated sialoglycans: a potent marker to monitor clinical status in childhood acute lymphoblastic leukemia.
Pal S; Bandyopadhyay S; Chatterjee M; Bhattacharya DK; Minto L; Hall AG; Mandal C
Clin Biochem; 2004 May; 37(5):395-403. PubMed ID: 15087256
[TBL] [Abstract][Full Text] [Related]
7. Increased interferon gamma production by peripheral blood mononuclear cells in response to stimulation of overexpressed disease-specific 9-O-acetylated sialoglycoconjugates in children suffering from acute lymphoblastic leukaemia.
Ghosh S; Bandyopadhyay S; Pal S; Das B; Bhattacharya DK; Mandal C
Br J Haematol; 2005 Jan; 128(1):35-41. PubMed ID: 15606547
[TBL] [Abstract][Full Text] [Related]
8. Interferon gamma promotes survival of lymphoblasts overexpressing 9-O-acetylated sialoglycoconjugates in childhood acute lymphoblastic leukaemia (ALL).
Ghosh S; Bandyopadhyay S; Mallick A; Pal S; Vlasak R; Bhattacharya DK; Mandal C
J Cell Biochem; 2005 May; 95(1):206-16. PubMed ID: 15770663
[TBL] [Abstract][Full Text] [Related]
9. Identification of 9-O acetyl sialoglycoconjugates (9-OAcSGs) as biomarkers in childhood acute lymphoblastic leukemia using a lectin, AchatininH, as a probe.
Sinha D; Mandal C; Bhattacharya DK
Leukemia; 1999 Jan; 13(1):119-25. PubMed ID: 10049046
[TBL] [Abstract][Full Text] [Related]
10. Altered erythrocyte membrane characteristics during anemia in childhood acute lymphoblastic leukemia.
Ghosh S; Bandyopadhyay S; Bhattacharya DK; Mandal C
Ann Hematol; 2005 Feb; 84(2):76-84. PubMed ID: 15338196
[TBL] [Abstract][Full Text] [Related]
11. Differential expression of 9-O-acetylated sialoglycoconjugates on leukemic blasts: a potential tool for long-term monitoring of children with acute lymphoblastic leukemia.
Pal S; Ghosh S; Bandyopadhyay S; Mandal C; Bandhyopadhyay S; Kumar Bhattacharya D; Mandal C
Int J Cancer; 2004 Aug; 111(2):270-7. PubMed ID: 15197782
[TBL] [Abstract][Full Text] [Related]
12. Identification and purification of cytolytic antibodies directed against O-acetylated sialic acid in childhood acute lymphoblastic leukemia.
Pal S; Chatterjee M; Bhattacharya DK; Bandhyopadhyay S; Mandal C
Glycobiology; 2000 Jun; 10(6):539-49. PubMed ID: 10814695
[TBL] [Abstract][Full Text] [Related]
13. O-acetylation of sialic acids is required for the survival of lymphoblasts in childhood acute lymphoblastic leukemia (ALL).
Ghosh S; Bandyopadhyay S; Mukherjee K; Mallick A; Pal S; Mandal C; Bhattacharya DK; Mandal C
Glycoconj J; 2007 Jan; 24(1):17-24. PubMed ID: 17146715
[TBL] [Abstract][Full Text] [Related]
14. Antibodies directed against O-acetylated sialoglycoconjugates accelerate complement activation in Leishmania donovani promastigotes.
Bandyopadhyay S; Chatterjee M; Das T; Bandyopadhyay S; Sundar S; Mandal C
J Infect Dis; 2004 Dec; 190(11):2010-9. PubMed ID: 15529267
[TBL] [Abstract][Full Text] [Related]
15. O-acetylated sialic acids: multifaceted role in childhood acute lymphoblastic leukaemia.
Chowdhury S; Mandal C
Biotechnol J; 2009 Mar; 4(3):361-74. PubMed ID: 19296441
[TBL] [Abstract][Full Text] [Related]
16. Co-expression of 9-O-acetylated sialoglycoproteins and their binding proteins on lymphoblasts of childhood acute lymphoblastic leukemia: an anti-apoptotic role.
Mukherjee K; Chava AK; Bandyopadhyay S; Mallick A; Chandra S; Mandal C
Biol Chem; 2009 Apr; 390(4):325-35. PubMed ID: 19166321
[TBL] [Abstract][Full Text] [Related]
17. Regulation of O-acetylation of sialic acids by sialate-O-acetyltransferase and sialate-O-acetylesterase activities in childhood acute lymphoblastic leukemia.
Mandal C; Mandal C; Chandra S; Schauer R; Mandal C
Glycobiology; 2012 Jan; 22(1):70-83. PubMed ID: 21803834
[TBL] [Abstract][Full Text] [Related]
18. Comparative analysis of differential expression of sialic acids and adhesion molecules on mononuclear cells of bone marrow and peripheral blood in childhood acute lymphoblastic leukaemia at diagnosis and clinical remission.
Chowdhury S; Bandyopadhyay S; Chandra S; Mandal C
Indian J Biochem Biophys; 2007 Oct; 44(5):357-65. PubMed ID: 18341211
[TBL] [Abstract][Full Text] [Related]
19. Agalactosylated IgG antibodies depend on cellular Fc receptors for in vivo activity.
Nimmerjahn F; Anthony RM; Ravetch JV
Proc Natl Acad Sci U S A; 2007 May; 104(20):8433-7. PubMed ID: 17485663
[TBL] [Abstract][Full Text] [Related]
20. Fc optimization of therapeutic antibodies enhances their ability to kill tumor cells in vitro and controls tumor expansion in vivo via low-affinity activating Fcgamma receptors.
Stavenhagen JB; Gorlatov S; Tuaillon N; Rankin CT; Li H; Burke S; Huang L; Vijh S; Johnson S; Bonvini E; Koenig S
Cancer Res; 2007 Sep; 67(18):8882-90. PubMed ID: 17875730
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
